Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978291241> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W1978291241 endingPage "110" @default.
- W1978291241 startingPage "92" @default.
- W1978291241 abstract "The dose-related cardioprotective efficacy of the thromboxane A2/prostaglandin endoperoxide (TP) receptor antagonist, ifetroban (BMS-180291), was investigated in an anesthetized ferret model of myocardial ischemia (90 min) followed by reperfusion (5 h). Treatment was begun at either the 75th minute of ischemia or 5 min after initiating reperfusion. The magnitude of TP receptor blockade was evaluated by ex vivo platelet function. Additional experiments in ferrets tested the antithrombotic potency of ifetroban as an inhibitor of thrombotic cyclic flow reduction (CFR) in the stenosed abdominal aorta (Folts model). Continuous ifetroban infusions of 0.03, 0.1 and 0.3 mg/kg/h reduced myocardial infarct size from 22% of the left ventricle in vehicle-control ferrets to 20, 12 and 9%, respectively. These represented reductions in infarct size of 8, 43 and 56%. Delaying initiation of treatment with high-dose ifetroban until 5 min into reperfusion also significantly reduced infarct size by 45%. High-dose ifetroban treatment did not prevent neutrophil (PMNL) accumulation measured as tissue myeloperoxidase activity in infarcted tissue. At the end of the 5-hour reperfusion period, the low, medium and high doses produced 90, 98 and 98% blockade of platelet TP receptors, respectively, measured as inhibition of ex vivo platelet shape change responses to U-46,619. Ifetroban inhibited thrombotic CFR at a threshold dose of 0.03 +/- 0.004 mg/kg, which antagonized 92% of ferret platelet TP receptors. Thus, ifetroban exhibited cardioprotective and antithrombotic activities and was effective at doses producing > 90% TP receptor blockade. Cardioprotective activity was not associated with any reductions of PMNL accumulation in infarcted tissue and was demonstrable even when treatment was delayed until 5 min after initiation of reperfusion." @default.
- W1978291241 created "2016-06-24" @default.
- W1978291241 creator A5005235560 @default.
- W1978291241 creator A5061269826 @default.
- W1978291241 creator A5076079312 @default.
- W1978291241 date "1995-01-01" @default.
- W1978291241 modified "2023-09-27" @default.
- W1978291241 title "Dose-Related Cardioprotection by Ifetroban in Relation to Inhibition of Thrombosis and ex vivo Platelet Function" @default.
- W1978291241 doi "https://doi.org/10.1159/000139271" @default.
- W1978291241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7716179" @default.
- W1978291241 hasPublicationYear "1995" @default.
- W1978291241 type Work @default.
- W1978291241 sameAs 1978291241 @default.
- W1978291241 citedByCount "4" @default.
- W1978291241 crossrefType "journal-article" @default.
- W1978291241 hasAuthorship W1978291241A5005235560 @default.
- W1978291241 hasAuthorship W1978291241A5061269826 @default.
- W1978291241 hasAuthorship W1978291241A5076079312 @default.
- W1978291241 hasConcept C126322002 @default.
- W1978291241 hasConcept C150903083 @default.
- W1978291241 hasConcept C170493617 @default.
- W1978291241 hasConcept C185592680 @default.
- W1978291241 hasConcept C207001950 @default.
- W1978291241 hasConcept C26291073 @default.
- W1978291241 hasConcept C2776785769 @default.
- W1978291241 hasConcept C2777015399 @default.
- W1978291241 hasConcept C2778468042 @default.
- W1978291241 hasConcept C2779216453 @default.
- W1978291241 hasConcept C2779676291 @default.
- W1978291241 hasConcept C2781024287 @default.
- W1978291241 hasConcept C2993802102 @default.
- W1978291241 hasConcept C541997718 @default.
- W1978291241 hasConcept C71924100 @default.
- W1978291241 hasConcept C86803240 @default.
- W1978291241 hasConcept C89560881 @default.
- W1978291241 hasConcept C98274493 @default.
- W1978291241 hasConceptScore W1978291241C126322002 @default.
- W1978291241 hasConceptScore W1978291241C150903083 @default.
- W1978291241 hasConceptScore W1978291241C170493617 @default.
- W1978291241 hasConceptScore W1978291241C185592680 @default.
- W1978291241 hasConceptScore W1978291241C207001950 @default.
- W1978291241 hasConceptScore W1978291241C26291073 @default.
- W1978291241 hasConceptScore W1978291241C2776785769 @default.
- W1978291241 hasConceptScore W1978291241C2777015399 @default.
- W1978291241 hasConceptScore W1978291241C2778468042 @default.
- W1978291241 hasConceptScore W1978291241C2779216453 @default.
- W1978291241 hasConceptScore W1978291241C2779676291 @default.
- W1978291241 hasConceptScore W1978291241C2781024287 @default.
- W1978291241 hasConceptScore W1978291241C2993802102 @default.
- W1978291241 hasConceptScore W1978291241C541997718 @default.
- W1978291241 hasConceptScore W1978291241C71924100 @default.
- W1978291241 hasConceptScore W1978291241C86803240 @default.
- W1978291241 hasConceptScore W1978291241C89560881 @default.
- W1978291241 hasConceptScore W1978291241C98274493 @default.
- W1978291241 hasIssue "2" @default.
- W1978291241 hasLocation W19782912411 @default.
- W1978291241 hasLocation W19782912412 @default.
- W1978291241 hasOpenAccess W1978291241 @default.
- W1978291241 hasPrimaryLocation W19782912411 @default.
- W1978291241 hasRelatedWork W1978291241 @default.
- W1978291241 hasRelatedWork W2002950370 @default.
- W1978291241 hasRelatedWork W2023692142 @default.
- W1978291241 hasRelatedWork W2046455524 @default.
- W1978291241 hasRelatedWork W2066405046 @default.
- W1978291241 hasRelatedWork W2085597870 @default.
- W1978291241 hasRelatedWork W2094830724 @default.
- W1978291241 hasRelatedWork W2109552509 @default.
- W1978291241 hasRelatedWork W2472469044 @default.
- W1978291241 hasRelatedWork W2884078422 @default.
- W1978291241 hasVolume "50" @default.
- W1978291241 isParatext "false" @default.
- W1978291241 isRetracted "false" @default.
- W1978291241 magId "1978291241" @default.
- W1978291241 workType "article" @default.